The Role of T cell PPAR γ in mice with experimental inflammatory bowel disease

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Guri, Amir J ^a   Mohapatra, Saroj K ^a   Horne II, William T ^a   Hontecillas, Raquel ^a   Bassaganya Riera, Josep ^a  

^a VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR FOXP3; CYTOKINE; DEXTRAN SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CITRIC ACID CYCLE; COLON MUCOSA; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; GENE EXPRESSION REGULATION; INTESTINE ULCER; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; RIBOSOME; T LYMPHOCYTE; WEIGHT REDUCTION; WILD TYPE; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CHEMICALLY INDUCED DISORDER; COLON; DISEASE COURSE; DISEASE MODEL; GENETICS; INTESTINE MUCOSA; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLON; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PPAR GAMMA; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 77953248869     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-60     Document Type: Article

References (53)

1. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006, 12(Suppl 1):S3-9. 10.1097/01.MIB.0000195385.19268.68, 16378007.
2. Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez F, Rohrer J, Benninghoff AU, Hontecillas R. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 2004, 127(3):777-791. 10.1053/j.gastro.2004.06.049, 15362034.
3. Desreumaux P, Dubuquoy L. PPARgamma agonists as a new class of effective treatment for ulcerative colitis. Inflamm Bowel Dis 2009, 15(6):959-960. 10.1002/ibd.20765, 18798571.
4. Lewis JD, Lichtenstein GR, Deren JJ, Sands BE, Hanauer SB, Katz JA, Lashner B, Present DH, Chuai S, Ellenberg JH, et al. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology 2008, 134(3):688-695. 2276587, 18325386.
5. Straus DS, Glass CK. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 2007, 28(12):551-558. 10.1016/j.it.2007.09.003, 17981503.
6. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW, et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447(7148):1116-1120. 10.1038/nature05894, 2587297, 17515919.
7. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, Glass CK. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 2005, 437(7059):759-763. 10.1038/nature03988, 1464798, 16127449.
8. Hontecillas R, Wannemeulher MJ, Zimmerman DR, Hutto DL, Wilson JH, Ahn DU, Bassaganya-Riera J. Nutritional regulation of porcine bacterial-induced colitis by conjugated linoleic acid. J Nutr 2002, 132(7):2019-2027.
9. Bassaganya-Riera J, Hontecillas R. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin Nutr 2006, 25(3):454-465. 10.1016/j.clnu.2005.12.008, 16698153.
10. Evans NP, Misyak S, Schmelz EM, Guri AJ, Hontecillas R, Bassaganya-Riera J. CLA decreases inflammation-induced colorectal cancer in mice through activation of PPAR γ. J Nutr 2010, 140(3):515-21. 10.3945/jn.109.115642, 20089779.
11. Adachi M, Kurotani R, Morimura K, Shah Y, Sanford M, Madison BB, Gumucio DL, Marin HE, Peters JM, Young HA, et al. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut 2006, 55(8):1104-1113. 10.1136/gut.2005.081745, 1513267, 16547072.
12. Mohapatra S, Guri AJ, Climent M, Vives C, Carbo A, Horne WT, Hontecillas R, Bassaganya-Riera J. Immunoregulatory actions of epithelial cell PPARgamma at the colonic mucosa. PLoS One 2010, 20;5(4):e10215.
13. Shah Y, Morimura K, Gonzalez F. Expression of Peroxisome Proliferator-Activated Receptor-{gamma} in Macrophage Suppresses Experimentally-Induced Colitis. Am J Physiol Gastrointest Liver Physiol 2006,
14. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002, 20:495-549. 10.1146/annurev.immunol.20.100301.064816, 11861611.
15. Aharoni R, Sonego H, Brenner O, Eilam R, Arnon R. The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells. Immunol Lett 2007, 112(2):110-119. 10.1016/j.imlet.2007.07.009, 17719654.
16. Horino J, Fujimoto M, Terabe F, Serada S, Takahashi T, Soma Y, Tanaka K, Chinen T, Yoshimura A, Nomura S, et al. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice. Int Immunol 2008, 20(6):753-762. 10.1093/intimm/dxn033, 18381351.
17. Hontecillas R, Bassaganya-Riera J. Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis. J Immunol 2007, 178(5):2940-2949.
18. Wohlfert EA, Nichols FC, Nevius E, Clark RB. Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and-independent mechanisms. J Immunol 2007, 178(7):4129-4135.
19. Bassaganya-Riera J, Misyak S, Guri AJ, Hontecillas R. PPAR gamma is highly expressed in F4/80(hi) adipose tissue macrophages and dampens adipose-tissue inflammation. Cell Immunol 2009, 258(2):138-146. 10.1016/j.cellimm.2009.04.003, 2706276, 19423085.
20. Willems F, Vollstedt S, Suter M. Phenotype and function of neonatal DC. Eur J Immunol 2009, 39(1):26-35. 10.1002/eji.200838391, 19137537.
21. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5(10):R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
22. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004, 20(3):307-315. 10.1093/bioinformatics/btg405, 14960456.
23. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249-264. 10.1093/biostatistics/4.2.249, 12925520.
24. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, (36 Database):D480-484. 2238879, 18077471.
25. Mohapatra SK, Cole LE, Evans C, Sobral BW, Bassaganya-Riera J, Hontecillas R, Vogel SN, Crasta OR. Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection. BMC Infect Dis 10(1):10. 10.1186/1471-2334-10-10, 2826305, 20082697.
26. Smyth GK. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, New York: Springer, Gentleman R, Dudoit S, Irizarry R, Huber W.
27. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3. Article3.
28. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125(1-2):279-284. 10.1016/S0166-4328(01)00297-2, 11682119.
29. Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics 2007, 23(2):257-258. 10.1093/bioinformatics/btl567, 17098774.
30. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 2006, (34 Database):D354-357. 10.1093/nar/gkj102, 1347464, 16381885.
31. Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J, Caron M. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 2003, 311(2):372-379. 10.1016/j.bbrc.2003.10.013, 14592424.
32. Schreiber S, Rosenstiel P, Hampe J, Nikolaus S, Groessner B, Schottelius A, Kuhbacher T, Hamling J, Folsch UR, Seegert D. Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 2002, 51(3):379-385. 10.1136/gut.51.3.379, 1773344, 12171960.
33. Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, et al. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med 2001, 193(4):471-481. 10.1084/jem.193.4.471, 2195913, 11181699.
34. Katayama K, Wada K, Nakajima A, Mizuguchi H, Hayakawa T, Nakagawa S, Kadowaki T, Nagai R, Kamisaki Y, Blumberg RS, et al. A novel PPARgamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology 2003, 124(5):1315-1324. 10.1016/S0016-5085(03)00262-2, 12730872.
35. Dubuquoy L, Jansson EE, Deeb S, Rakotobe S, Karoui M, Colombel JF, Auwerx J, Pettersson S, Desreumaux P. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 2003, 124(5):1265-1276. 10.1016/S0016-5085(03)00271-3, 12730867.
36. Lytle C, Tod TJ, Vo KT, Lee JW, Atkinson RD, Straus DS. The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency. Inflamm Bowel Dis 2005, 11(3):231-243. 10.1097/01.MIB.0000160805.46235.eb, 15735429.
37. Guri AJ, Hontecillas R, Bassaganya-Riera J. Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration. Clinical Nutrition 2010,
38. Reindl W, Weiss S, Lehr HA, Forster I. Essential crosstalk between myeloid and lymphoid cells for development of chronic colitis in myeloid-specific signal transducer and activator of transcription 3-deficient mice. Immunology 2007, 120(1):19-27. 10.1111/j.1365-2567.2006.02473.x, 2265865, 17233738.
39. Takedatsu H, Michelsen KS, Wei B, Landers CJ, Thomas LS, Dhall D, Braun J, Targan SR. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 2008, 135(2):552-567. 10.1053/j.gastro.2008.04.037, 2605110, 18598698.
40. Kanwar B, Gao DW, Hwang AB, Grenert JP, Williams SP, Franc B, McCune JM. In vivo imaging of mucosal CD4+ T cells using single photon emission computed tomography in a murine model of colitis. J Immunol Methods 2008, 329(1-2):21-30. 10.1016/j.jim.2007.09.008, 2683264, 17964595.
41. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H. IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 2000, 164(9):4878-4882.
42. Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med 2000, 6(5):583-588. 10.1038/75068, 10802717.
43. Kwon KH, Murakami A, Hayashi R, Ohigashi H. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis. Biochem Biophys Res Commun 2005, 337(2):647-654. 10.1016/j.bbrc.2005.09.107, 16202978.
44. Sans M, Panes J, Ardite E, Elizalde JI, Arce Y, Elena M, Palacin A, Fernandez-Checa JC, Anderson DC, Lobb R, et al. VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology 1999, 116(4):874-883. 10.1016/S0016-5085(99)70070-3, 10092309.
45. Reed KL, Fruin AB, Gower AC, Gonzales KD, Stucchi AF, Andry CD, O'Brien M, Becker JM. NF-kappaB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci 2005, 50(12):2366-2378. 10.1007/s10620-005-3066-y, 16416193.
46. Balasubramanian K, Kumar S, Singh RR, Sharma U, Ahuja V, Makharia GK, Jagannathan NR. Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. Magn Reson Imaging 2009, 27(1):79-86. 10.1016/j.mri.2008.05.014, 18599242.
47. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995, 270(22):12953-12956. 10.1074/jbc.270.22.12953, 7768881.
48. Taylor DJ, Faragher EB, Evanson JM. Inflammatory cytokines stimulate glucose uptake and glycolysis but reduce glucose oxidation in human dermal fibroblasts in vitro. Circ Shock 1992, 37(2):105-110.
49. Kucharczak J, Simmons MJ, Fan Y, Gelinas C. To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003, 22(56):8961-8982. 10.1038/sj.onc.1207230, 14663476.
50. Wahli W. A gut feeling of the PXR, PPAR and NF-kappaB connection. J Intern Med 2008, 263(6):613-619. 10.1111/j.1365-2796.2008.01951.x, 18479261.
51. Bou-Fersen AM, Anim JT, Khan I. Experimental colitis is associated with ultrastructural changes in inflamed and uninflamed regions of the gastrointestinal tract. Med Princ Pract 2008, 17(3):190-196. 10.1159/000117791, 18408386.
52. Yoneda T, Imaizumi K, Oono K, Yui D, Gomi F, Katayama T, Tohyama M. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem 2001, 276(17):13935-13940.
53. Melgar S, Karlsson A, Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 2005, 288(6):G1328-1338. 10.1152/ajpgi.00467.2004, 15637179.